Related Experiment Video
Updated: Jan 18, 2026

Encapsulating Cytochrome c in Silica Aerogel Nanoarchitectures without Metal Nanoparticles while Retaining Gas-phase Bioactivity
Published on: March 1, 2016
Effective and Stable Senomorphic Apigenin Delivery System Obtained by Supercritical Carbon Dioxide Processing
Anna Stasiłowicz-Krzemień1, Natalia Rosiak1, Giuseppe Francesco Racaniello2
1Department of Pharmacognosy and Biomaterials, Poznan University of Medical Sciences, Rokietnicka 3 Str., 60-806 Poznan, Poland.
This study developed a stable amorphous dispersion of apigenin (AP) using supercritical carbon dioxide and Soluplus, significantly enhancing its solubility and bioavailability. The improved formulation demonstrated superior antioxidant and neuroprotective effects, overcoming AP
Area of Science:
- Pharmacology and Pharmaceutical Sciences
- Materials Science
- Biochemistry
Background:
- Apigenin (AP), a natural flavonoid, possesses senomorphic and neuroprotective properties.
- Poor aqueous solubility of AP (<1 μg/mL) severely limits its bioavailability and therapeutic applications.
- Developing strategies to enhance AP solubility is crucial for its effective utilization.
Purpose of the Study:
- To create a stable amorphous dispersion of apigenin (AP) using supercritical carbon dioxide (scCO2) processing.
- To evaluate the enhanced solubility, bioavailability, and biological activities of the AP amorphous dispersion.
- To confirm the stability and characterize the intermolecular interactions within the AP dispersion.
Main Methods:
- Screening of AP solubilization with Soluplus (SOL) under scCO2 conditions.
- Optimization of scCO2 processing parameters (temperature, pressure) for maximum AP solubility.
- Characterization using X-ray powder diffraction (XRPD), PAMPA model, ATR-FT-IR, and chromatographic analysis.
- Assessment of antioxidant (DPPH, ABTS, CUPRAC) and anticholinesterase (AChE, BChE) activities.
Main Results:
- Soluplus significantly improved AP dissolution, reaching 8050.2 ± 35.1 μg/mL under optimized scCO2 conditions.
- XRPD confirmed amorphization, leading to enhanced AP dissolution across acidic and neutral pH.
- Improved membrane penetration (gastrointestinal and blood-brain barriers) and 12-month stability of the amorphous dispersion.
- Enhanced antioxidant and neuroprotective activities (anticholinesterase inhibition) correlated with improved solubility.
Conclusions:
- A stable amorphous AP dispersion was successfully prepared using scCO2 and Soluplus, exhibiting excellent solubility and stability.
- The developed formulation demonstrates enhanced passive diffusion across biological membranes.
- The improved AP dispersion offers greater potential for effective antioxidant and neuroprotective therapies.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Bioavailability Enhancement: Drug Permeability Enhancement

